Re: Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer. . J Urol 2020 Oct 7:101097JU0000000000001403. doi: 10.1097/JU.0000000000001403.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

. Re: Testosterone Breakthrough Rates during Androgen Deprivation Therapy for Castration Sensitive Prostate Cancer. J Urol 2020 Oct 7:101097JU0000000000001403. doi: 10.1097/JU.0000000000001403.
PMID: 33026926